#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary mediastinal large B-cell lymphoma Methylmalonic acidaemia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Pulmonary arterial hypertension Philadelphia chromosome positive High-grade B-cell lymphoma Rhabdoid tumour Red blood cell abnormality Short-bowel syndrome Acute myeloid leukaemia Ureteric cancer Mixed-type liposarcoma Leukoencephalopathy Adrenogenital syndrome Dermatomyositis More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome – Basic Information Medulloblastoma – Diagnostics Rhabdomyosarcoma recurrent Biotinidase deficiency – Treatment Osteosarcoma – Diagnostics Pemphigoid – Life with Disease Usher’s syndrome – Basic Information Glycogen storage disease type I – Life with Disease Choroid melanoma – Trials in Disease Vascular malformation – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elezanumab Dexmedetomidine Vidofludimus Calcium Dextrose Bp Pelareorep Antipsychotics Metformin Embonate Afm24 Rugonersen Ambrisentan Sodium Oxybate Masofaniten Etifoxine Hydrochloride Insulin Icodec Avelumab 7-Ethyl-10-Hydroxycamptothecin Gallium (68Ga) Chloride Aon-D21 HSP-CAR30 Glasdegib More therapies…

    Learn about Your Condition

    Hydrocephalus Sleep disorder Stevens-Johnson syndrome Retinal vein occlusion Torticollis Actinic cheilitis Oxygen therapy IgA nephropathy Herpes simplex reactivation Meningioma Palpitations Radicular pain Amyotrophic lateral sclerosis Infective uveitis Rectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rhinitis allergic

  • Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
    Germany Poland

  • Study on the Effectiveness of Intralyphatic Immunotherapy with Vitamin D for Patients with Allergic Rhinitis Using Phleum Pratense and Colecalciferol

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Rhinitis allergic
    Investigated Drugs:
    • Phleum Pratense (225)
    • Colecalciferol
    • Glycerol
    Sweden

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Agrostis Stolonifera Pollen
    • Alnus Glutinosa Pollen
    • Aluminium Hydroxide
    Austria Bulgaria Germany Latvia Lithuania Poland

  • Study on the Effectiveness and Safety of Sublingual Immunotherapy with Betula Pendula Pollen Extract for Patients with Birch Pollen Allergy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Rhinitis allergic
    Investigated Drugs:
    • Alternaria Alternata (402)
    • Alternaria Alternata Extract
    • Ambrosia Artemisiifolia (302)
    Germany
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!